首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Theranostics

Theranostics杂志,由Ivyspring International Publisher出版,于2011年创刊,1 issue/year,出版语言English,ISSN:1838-7640,E-ISSN:1838-7640。

投稿咨询
Theranostics
Theranostics
Theranostics
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
14.9
CiteScore
23.9
期刊收录
SCI、SCIE

Theranostics(中文译名:《Theranostics》),ISSN:1838-7640,EISSN:1838-7640,是Ivyspring International Publisher出版的国际性学术期刊,创刊于2011年,以1 issue/year形式稳定发行,2026年总发文量约502篇。该刊采用OA开放访问,学科归属为MEDICINE, RESEARCH & EXPERIMENTAL。该刊是医学、医学研究与实验领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达14.9,2025年期刊CiteScore为0,2025年期刊自引率约1.3%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Theranostics长期聚焦医学、医学研究与实验及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、医学研究与实验领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、GERMANY (FED REP GER)、South Korea、Taiwan、France、Australia等为核心发文国家与地区;CHINESE ACADEMY OF SCIENCESSHANGHAI JIAO TONG UNIVERSITY、SUN YAT SEN UNIVERSITY、FUDAN UNIVERSITY、HUAZHONG UNIVERSITY OF SCIENCE & TECHNOLOGY、ZHEJIANG UNIVERSITY、PEKING UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 6 / 191

97.1

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 4 / 191

98.17

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 7 / 195

96.7

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 6 / 195

97.18


中国学者近期发文

1
From pathogenesis to treatment: the role of autophagic cell death in GONFH and its potential mitigation by naringeni

Author:Xu, Huihui; Huang, Haipeng; Zou, Kaiao; Yu, Xingfang; Zeng, Qinghe; Wu, Congzi; Chen, Wenzhe; Wang, Pinger; He, Bangjian; Xiao, Luwei; Chen, Jiali; Tong, Peijian; Jin, Hongting

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4804-4820. DOI: 10.7150/thno.129809

2
Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cance

Author:Xia, Peng; Qu, Ying; Liu, Quanzhong; Zhu, Mengyan; Huang, Bin; Wu, Wei; Li, Kening; Wu, Lingxiang; Zhang, Ruohan; Lv, Yingli; Wang, Qianghu

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4821-4840. DOI: 10.7150/thno.126314

3
promotes oncogenic signaling and therapeutic resistance in pancreatic cance

Author:Sun, Qihui; Li, Xiaojia; Zou, Qi; Chen, Yang; Zhu, Xiaoqi; Jiang, Hailin; Jiang, Tingting; We, Fang; Xie, Keping

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4745-4767. DOI: 10.7150/thno.113637

4
In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephriti

Author:Kuang, Huang; Lin, Cai-Xia; Huang, Jing; Li, Wen-Xuan; Zhu, Yu-Ge; Jiang, Nan; Li, Zhong; Li, Nan; Li, Ping; Jia, Xiao-Yu; Cui, Zhao; Zhao, Ming-Hui

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4787-4803. DOI: 10.7150/thno.126588

5
Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy (vol 15, pg 4823, 2025

Author:Khan, Mubassir; Ullah, Razi; Wang, Guixue; Chu, Maoquan

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4841-4842. DOI: 10.7150/thno.120915

6
H3K18 lactylation-mediated SPHK1-SIRT1 feedback loop accelerates pyroptosis of tubular epithelial cells in sepsis-associated acute kidney injur

Author:Huang, Yan; Zhao, Eryang; Zhao, Guangyu; Zhuo, Wenfeng; Zhao, Yingsong; Wang, Hongda; Lv, Guozheng; Hu, Rong; Zeng, Zhu; Han, Shengbo; Hu, Yuhang; Zhao, Gang

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4768-4786. DOI: 10.7150/thno.122991

7
Molecular hydrogen triggers TRPC4-TRPC4AP-dependent reversible calcium transients via extracellular influ

Author:Zhao, Pengxiang; Li, Han; Cai, Zisong; Zhang, Xujuan; Wen, Xiaohu; Liu, Ziyi; Jiang, Shihao; Jiang, Xue; Wang, Jiateng; Dang, Zheng; Liu, Mengyu; Xie, Fei; Ma, Xuemei

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4843-4864. DOI: 10.7150/thno.124352

8
From bench to bedside: the promise and roadblocks of extracellular vesicl

Author:Zhang, Jing; Pan, Yuanwei; She, Peng; Rao, Lang

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 5044-5064. DOI: 10.7150/thno.131621

9
Recent advances of metal-organic frameworks (MOFs) for drug delivery, cancer imaging and theranostic

Author:Yu, Honglian; Lin, Gan; Mi, Peng

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4980-5015. DOI: 10.7150/thno.128435

10
Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor-reactive CX3CR1+GPR56+ T cells in hepatocellular carcinom

Author:Wang, Shicheng; Wang, Ying; Zhang, Yan; Zhang, Zelu; Huang, Haozhe; Xu, Lichao; Hao, Yuankai; Lou, Yue; Wang, Ke; Li, Wentao; Liu, Ping; Xu, Lisa X.; Su, Bing

Journal: THERANOSTICS. 2026; Vol. 16, Issue 9, pp. 4959-4979. DOI: 10.7150/thno.127962


在线咨询

Theranostics

国际简称:THERANOSTICS参考译名:Theranostics

年发文量:502 CiteScore:23.9 是否预警:否 Gold OA文章占比:99.92% 研究类文章占比:82.47%

杂志社联系方式:PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263

Theranostics